Login / Signup

[Direct and indirect neurological manifestations of COVID-19].

O A GromovaIvan Yu TorshinV A SemenovM V PutilinaA G Chuchalin
Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2020)
In the long term, COVID-19 stimulates neurodegenerative changes, which require specific programs of neurological rehabilitation. It is advisable to use choline drugs and antihypoxants that are compatible with COVID-19 therapy.
Keyphrases
  • coronavirus disease
  • sars cov
  • public health
  • bone marrow
  • cell therapy
  • drug induced